Exosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges
Neurodegenerative diseases constitute a group of pathologies whose etiology remains unknown in many cases, and there are no treatments that stop the progression of such diseases. Moreover, the existence of the blood–brain barrier is an impediment to the penetration of exogenous molecules, including...
Main Authors: | Amanda Cano, Álvaro Muñoz-Morales, Elena Sánchez-López, Miren Ettcheto, Eliana B. Souto, Antonio Camins, Mercè Boada, Agustín Ruíz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/1/298 |
Similar Items
-
Engineered Extracellular Vesicles/Exosomes as a New Tool against Neurodegenerative Diseases
by: Flavia Ferrantelli, et al.
Published: (2020-06-01) -
Biodegradable nanoparticles for the treatment of epilepsy: From current advances to future challenges
by: Lorena Bonilla, et al.
Published: (2022-08-01) -
Extracellular vesicles in neurodegenerative diseases: Insights and new perspectives
by: Qian Yuan, et al.
Published: (2021-03-01) -
Transnasal-brain delivery of nanomedicines for neurodegenerative diseases
by: Xu Zhang, et al.
Published: (2023-08-01) -
Extracellular vesicles in nanomedicine and regenerative medicine: A review over the last decade
by: Saeid Moghassemi, et al.
Published: (2024-06-01)